Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Pharmaceuticals & Drugs - Domestic

Rating :
N/A

BSE: 509079 | NSE: GUFICBIO

432.30
20-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  438.55
  •  450.25
  •  430.00
  •  441.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  73992
  •  326.25
  •  504.25
  •  277.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,327.48
  • 50.95
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,591.68
  • 0.02%
  • 7.54

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.51%
  • 4.96%
  • 16.01%
  • FII
  • DII
  • Others
  • 0.23%
  • 2.51%
  • 3.78%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.20
  • 16.32
  • 1.16

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 26.17
  • 22.86
  • -0.29

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 35.40
  • 30.58
  • -3.49

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 34.71
  • 28.77
  • 29.25

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.51
  • 7.51
  • 7.19

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.10
  • 18.78
  • 20.31

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
8.59
P/E Ratio
48.81
Revenue
807
EBITDA
146
Net Income
86
ROA
8.8
P/Bk Ratio
7.9
ROE
19.57
FCFF
-127.24
FCFF Yield
-2.87

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
204.18
214.87
-4.98%
202.81
0.00
0
194.99
0.00
0
201.78
0.00
0
Expenses
165.56
175.50
-5.66%
167.03
0.00
0
160.77
0.00
0
165.32
0.00
0
EBITDA
38.62
39.37
-1.91%
35.78
0.00
0
34.23
0.00
0
36.45
0.00
0
EBIDTM
18.91%
18.32%
17.64%
0.00%
17.55%
0.00%
18.07%
0.00%
Other Income
0.11
0.33
-66.67%
1.26
0.00
0
0.88
0.00
0
0.42
0.00
0
Interest
5.18
4.46
16.14%
4.62
0.00
0
3.65
0.00
0
3.18
0.00
0
Depreciation
4.30
4.30
0.00%
4.30
0.00
0
4.34
0.00
0
4.14
0.00
0
PBT
29.25
30.95
-5.49%
28.11
0.00
0
27.12
0.00
0
29.56
0.00
0
Tax
7.48
7.74
-3.36%
7.25
0.00
0
7.07
0.00
0
7.30
0.00
0
PAT
21.77
23.21
-6.20%
20.86
0.00
0
20.05
0.00
0
22.26
0.00
0
PATM
10.66%
10.80%
10.28%
0.00%
10.28%
0.00%
11.03%
0.00%
EPS
2.17
2.39
-9.21%
2.08
0.00
0
2.00
0.00
0
2.22
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Net Sales
-
806.67
Net Sales Growth
-
 
Cost Of Goods Sold
-
339.06
Gross Profit
-
467.60
GP Margin
-
57.97%
Total Expenditure
-
660.79
Power & Fuel Cost
-
17.79
% Of Sales
-
2.21%
Employee Cost
-
109.63
% Of Sales
-
13.59%
Manufacturing Exp.
-
89.75
% Of Sales
-
11.13%
General & Admin Exp.
-
53.61
% Of Sales
-
6.65%
Selling & Distn. Exp.
-
40.20
% Of Sales
-
4.98%
Miscellaneous Exp.
-
10.75
% Of Sales
-
1.33%
EBITDA
-
145.88
EBITDA Margin
-
18.08%
Other Income
-
2.18
Interest
-
15.36
Depreciation
-
17.02
PBT
-
115.67
Tax
-
29.54
Tax Rate
-
25.54%
PAT
-
86.14
PAT before Minority Interest
-
86.14
Minority Interest
-
0.00
PAT Margin
-
10.68%
PAT Growth
-
 
EPS
-
8.59

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Shareholder's Funds
532.56
Share Capital
10.03
Total Reserves
522.53
Non-Current Liabilities
187.93
Secured Loans
153.96
Unsecured Loans
0.00
Long Term Provisions
15.38
Current Liabilities
372.05
Trade Payables
166.27
Other Current Liabilities
56.48
Short Term Borrowings
142.02
Short Term Provisions
7.28
Total Liabilities
1,092.54
Net Block
158.89
Gross Block
246.23
Accumulated Depreciation
87.34
Non Current Assets
492.06
Capital Work in Progress
307.06
Non Current Investment
1.78
Long Term Loans & Adv.
23.12
Other Non Current Assets
1.21
Current Assets
600.48
Current Investments
0.00
Inventories
200.48
Sundry Debtors
329.94
Cash & Bank
13.48
Other Current Assets
56.58
Short Term Loans & Adv.
52.83
Net Current Assets
228.43
Total Assets
1,092.54

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Cash From Operating Activity
-7.46
PBT
115.67
Adjustment
34.15
Changes in Working Capital
-130.23
Cash after chg. in Working capital
19.59
Interest Paid
0.00
Tax Paid
-27.04
Other Direct Exp. Paid
0.00
Extra & Other Items
0.00
Cash From Investing Activity
-102.39
Net Fixed Assets
Net Investments
Others
Cash from Financing Activity
82.38
Net Cash Inflow / Outflow
-27.46
Opening Cash & Equivalents
28.60
Closing Cash & Equivalent
1.14

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Book Value (Rs.)
53.11
ROA
7.88%
ROE
16.17%
ROCE
15.42%
Fixed Asset Turnover
3.82
Receivable days
128.09
Inventory Days
77.83
Payable days
178.99
Cash Conversion Cycle
26.94
Total Debt/Equity
0.60
Interest Cover
8.53

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.